Hemorrhage Rates and Risk Factors in the Natural History Course of Brain Arteriovenous Malformations

Translational Stroke Research

Volumn 5, Issue 5, 2014, Pages 538-542

  Rutledge, W Caleb ^a   Ko, Nerissa U ^a   Lawton, Michael T ^a   Kim, Helen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arteriovenous malformation; Epidemiology; Intracerebral hemorrhage; Natural history; Risk factor; Survival; Treatment

Indexed keywords

BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; DISEASE COURSE; HEREDITY; HUMAN; MEDICAL HISTORY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURVIVAL; ARTERIOVENOUS FISTULA; INCIDENCE; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; INTRACRANIAL HEMORRHAGES;

ARTERIOVENOUS FISTULA; HUMANS; INCIDENCE; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; INTRACRANIAL HEMORRHAGES; RISK FACTORS;

EID: 84905575044     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0351-0     Document Type: Review

References (51)

1. van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Salman RA. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132(Pt 2): 537-43.
2. Fults D, Kelly Jr DL. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery. 1984;15(5): 658-62.
3. Brown Jr RD, Wiebers DO, Forbes G, O'Fallon WM, Piepgras DG, Marsh WR, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988;68(3): 352-7.
4. Al-Shahi R, Fang JS, Lewis SC, Warlow CP. Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry. 2002;73(5): 547-51.
5. Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly Jr ES, Mohr JP, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47(2): 389-96.
6. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, et al. The New York islands AVM study: design, study progress, and initial results. Stroke. 2003;34(5): e29-33.
7. Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish intracranial vascular malformation study (SIVMS). Stroke. 2003;34(5): 1163-9.
8. Gabriel RA, Kim H, Sidney S, McCulloch CE, Singh V, Johnston SC, et al. Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010;41(1): 21-6.
9. Laakso A, Dashti R, Seppanen J, Juvela S, Vaart K, Niemela M, et al. Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery. 2008;63(2): 244-53.
10. Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke. 2004;35(7): 1697-702.
11. Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke. 2007;38(9): 2430-37.
12. Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry. 1986;49(1): 1-10.
13. Itoyama Y, Uemura S, Ushio Y, Kuratsu J, Nonaka N, Wada H, et al. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg. 1989;71(6): 805-9.
14. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084): 1065-8.
15. Stefani MA, Porter PJ, TerBrugge KG, Montanera W, Willinsky RA, Wallace MC. Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke. 2002;33(5): 1220-4.
16. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9): 1350-5.
17. Yamada S, Takagi Y, Nozaki K, Kikuta K, Hashimoto N. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg. 2007;107(5): 965-72.
18. Hernesniemi JA, Dashti R, Juvela S, Vaart K, Niemela M, Laakso A. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5): 823-31.
19. da Costa L, Wallace MC, Ter Brugge KG, O'Kelly C, Willinsky RA, Tymianski M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 2009;40(1): 100-5.
20. Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2013;118(2): 437-43.
21. Kim H, McCulloch CE, Johnston SC, Lawton MT, Sidney S, Young WL. Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol. 2010;171(12): 1317-22.
22. Pollock BE, Flickinger JC, Lunsford LD, Bissonette DJ, Kondziolka D. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke. 1996;27(1): 1-6.
23. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg. 2003;98(1): 3-7.
24. Karlsson B, Lindquist C, Johansson A, Steiner L. Annual risk for the first hemorrhage from untreated cerebral arteriovenous malformations. Minim Invasive Neurosurg. 1997;40(2): 40-6.
25. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917): 614-21.
26. Fullerton HJ, Achrol AS, Johnston SC, McCulloch CE, Higashida RT, Lawton MT, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke. 2005;36(10): 2099-104.
27. Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King Jr JT. Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery. 1998;42(3): 481-6.
28. Spetzler RF, Hargraves RW, McCormick PW, Zabramski JM, Flom RA, Zimmerman RS. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg. 1992;76(6): 918-23.
29. Mine S, Hirai S, Ono J, Yamaura A. Risk factors for poor outcome of untreated arteriovenous malformation. J Clin Neurosci. 2000;7(6): 503-6.
30. Halim AX, Singh V, Johnston SC, Higashida RT, Dowd CF, Halbach VV, et al. Characteristics of brain arteriovenous malformations with coexisting aneurysms: a comparison of two referral centers. Stroke. 2002;33(3): 675-9.
31. Stapf C, Mohr JP, Pile-Spellman J, Sciacca RR, Hartmann A, Schumacher HC, et al. Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation. J Neurol Neurosurg Psychiatry. 2002;73(3): 294-8.
32. Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, et al. Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke. 2004;35(10): 2294-300.
33. Weinsheimer S, Kim H, Pawlikowska L, Chen Y, Lawton MT, Sidney S, et al. EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations. Circ Cardiovasc Genet. 2009;2(5): 476-82.
34. Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, et al. Tumor necrosis factor-alpha-238G > A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke. 2006;37(1): 231-4.
35. Pawlikowska L, Poon KY, Achrol AS, McCulloch CE, Ha C, Lum K, et al. Apoliprotein E epsilon2 is associated with new hemorrhage risk in brain arteriovenous malformation. Neurosurgery. 2006;58(5): 838-43.
36. Kim H, Hysi PG, Pawlikowska L, Poon A, Burchard EG, Zaroff JG, et al. Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis. 2009;27(2): 176-82.
37. Achrol AS, Kim H, Pawlikowska L, Poon KY, Ko NU, McCulloch CE, et al. Association of tumor necrosis factor-alpha-238G > A and Apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery. 2007;61(4): 731-9.
38. Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, et al. Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol. 2006;59(1): 72-80.
39. Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y, et al. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci. 2006;11: 3121-8.
40. Chen Y, Zhu W, Bollen AW, Lawton MT, Barbaro NM, Dowd CF, et al. Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery. 2008;62(6): 1340-9.
41. Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly Jr T, Stewart CL, et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery. 2004;54(2): 410-23.
42. Weinsheimer S, Xu H, Achrol AS, Stamova B, McCulloch CE, Pawlikowska L, et al. Gene expression profiling of blood in brain arteriovenous malformation patients. Trans Stroke Res. 2011;2(4): 575-87.
43. Chen W, Guo Y, Walker EJ, Shen F, Jun K, Oh SP, et al. Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. Arterioscler Thromb Vasc Biol. 2013;33(2): 305-10.
44. Walker EJ, Su H, Shen F, Choi EJ, Oh SP, Chen G, et al. Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol. 2011;69(6): 954-62.
45. Guo Y, Saunders T, Su H, Kim H, Akkoc D, Saloner DA, et al. Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke. 2012;43(5): 1240-46.
46. Chalouhi N, Jabbour P, Magnotta V, Hasan D. Molecular imaging of cerebrovascular lesions. Trans Stroke Res. 2014;5(2): 260-8.
47. Hasan DM, Amans M, Tihan T, Hess C, Guo Y, Cha S. Ferumoxytol-enhanced MRI to image inflammation within human brain arteriovenous malformations: a pilot investigation. Trans Stroke Res. 2012;3(Supplement 1): 166-73.
48. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4): 476-83.
49. Spetzler RF, Ponce FA. A 3-tier classification of cerebral arteriovenous malformations. Clin Article J Neurosurg. 2011;114(3): 842-9.
50. Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2010;66(4): 702-13.
51. Kim H, Pourmohamad T, Westbroek EM, McCulloch CE, Lawton MT, Young WL. Evaluating performance of the Spetzler-Martin supplemented model in selecting patients with arteriovenous malformation patients for surgery. Stroke. 2012;43(9): 2497-9.